We are live on
!
Find out more
MG
Meditor Group Portfolio holdings
AUM
$48.1M
1-Year Est. Return
38.67%
This Fund
S&P 500
This Quarter
Est. Return
+8.52%
1 Year Est. Return
+38.67%
3 Year Est. Return
+41.15%
5 Year Est. Return
+72.2%
10 Year Est. Return
+1,065.64%
AUM
$135M
AUM Growth
-$574M
(-81%)
Cap. Flow
-$585M
Cap. Flow
% of AUM
-432.5%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
36
New
–
Increased
–
Reduced
3
Closed
33
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$83.2M |
| 2 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$54.2M |
| 3 |
JCP
J.C. Penney Company, Inc.
JCP
|
+$39.6M |
| 4 |
BKS
Barnes & Noble
BKS
|
+$36.9M |
| 5 |
NYX
NYSE EURONEXT INC
NYX
|
+$32.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| 2 | Consumer Discretionary | 0% |
| 3 | Energy | 0% |
| 4 | Financials | 0% |
| 5 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Exelixis
EXEL
$13.9B
| $64.6M | 47.71% |
10,533,384
-1,466,616
| -12% | -$8.08M |
|
2
Alkermes
ALKS
$8.82B
| $41.9M | 30.96% |
1,030,639
-539,361
| -34% | -$19.9M |
|
|
VVUS
3
DELISTED
Vivus Inc
VVUS
| $28.9M | 21.33% |
317,862
-102,868
| -24% | -$9.94M |
|
4
Apple
AAPL
$4.89T
| – | – |
-840,000
| Closed | -$14.3M |
|
5
Bank of America
BAC
$435B
| – | – |
-244,000
| Closed | -$3.37M |
|
6
BioMarin Pharmaceuticals
BMRN
$11.5B
| – | – |
-55,100
| Closed | -$3.98M |
|
7
Carnival Corporation Ltd
CCL
$36.1B
| – | – |
-45,600
| Closed | -$1.49M |
|
8
Delta Air Lines
DAL
$55.9B
| – | – |
-124,000
| Closed | -$2.92M |
|
9
Dillards
DDS
$8.87B
| – | – |
-245,000
| Closed | -$19.2M |
|
10
Alphabet (Google) Class C
GOOG
$3.9T
| – | – |
-941,596
| Closed | -$20.5M |
|
11
Gran Tierra Energy
GTE
$260M
| – | – |
-6,300
| Closed | -$461K |
|
12
Halliburton
HAL
$27.9B
| – | – |
-31,000
| Closed | -$1.49M |
|
13
HP
HPQ
$23.5B
| – | – |
-2,546,443
| Closed | -$24.3M |
|
14
Herc Holdings
HRI
$5.43B
| – | – |
-4,000
| Closed | -$266K |
|
15
Ionis Pharmaceuticals
IONS
$9.35B
| – | – |
-490,000
| Closed | -$18.4M |
|
16
Liberty Global Class C
LBTYK
$3.27B
| – | – |
-418,428
| Closed | -$12.8M |
|
|
17
Merck
MRK
$324B
| – | – |
-1,830,437
| Closed | -$83.2M |
|
18
Micron Technology
MU
$1.04T
| – | – |
-155,000
| Closed | -$2.71M |
|
19
Neurocrine Biosciences
NBIX
$17.7B
| – | – |
-1,050,000
| Closed | -$11.9M |
|
20
Nektar Therapeutics
NKTR
$2.39B
| – | – |
-96,667
| Closed | -$15.1M |
|
21
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| – | – |
-107,708
| Closed | -$18.1M |
|
22
Universal Health Services
UHS
$9.43B
| – | – |
-210,000
| Closed | -$15.7M |
|
23
Vale
VALE
$62.9B
| – | – |
-219,400
| Closed | -$3.42M |
|
|
INFN
24
DELISTED
Infinera Corporation Common Stock
INFN
| – | – |
-24,400
| Closed | -$276K |
|
|
JCP
25
DELISTED
J.C. Penney Company, Inc.
JCP
| – | – |
-4,500,000
| Closed | -$39.6M |
|
Similar funds
BHCM
VMV
BHH
LAMC
MAM
BCM
LOF
CLCM
Meditor Group's Q4 2013 Portfolio in Review
As of Q4 2013, Meditor Group held 36 positions worth $135M, down 81% from $709M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Meditor Group withdrew a net $585M in Q4 2013, closing 33 positions and reducing 3 holdings. Its most notable exit was Merck, an estimated $83.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 47% a quarter earlier, followed by Consumer Discretionary and Energy.
- Meditor Group's biggest Q4 2013 reduction was Alkermes, cutting an estimated $19.9M.
- Meditor Group fully exited Merck in Q4 2013, selling an estimated $83.2M.
- Meditor Group's ten largest holdings make up 100% of its $135M portfolio in Q4 2013.
- Meditor Group opened 0 new positions and closed 33 in Q4 2013.
- Meditor Group's portfolio value fell 81% quarter-over-quarter to $135M.
Based on Meditor Group's 13F filing for Q4 2013, filed 21 Jan 2014.